AI Conversational Agent to Improve Varenicline Adherence: Protocol for a Mixed Methods Feasibility Study
Nadia Minian, Kamna Mehra, Mackenzie Earle, Sowsan Hafuth, Ryan Ting-A-Kee, Jonathan Rose, Scott Veldhuizen, Laurie Zawertailo, Matt Ratto, Osnat C Melamed, Peter Selby · 2023
Read AI Conversational Agent to Improve Varenicline Adherence: Protocol for a Mixed Methods Feasibility Study by Nadia Minian, Kamna Mehra, Mackenzie Earle, Sowsan Hafuth, Ryan Ting-A-Kee, Jonathan Rose, Scott Veldhuizen, Laurie Zawertailo, Matt Ratto, Osnat C Melamed, Peter Selby (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10750231.txt.
Description
Nadia Minian and co-authors set out a protocol to test ChatV, a chatbot that helps smokers stick to the quit drug varenicline. Published in 2023, the plan addresses a known leak: a third of users stop taking the drug by week two, though steady use raises the odds of quitting for good. The bot gives reminders, answers drug questions, and tracks doses and cigarettes.
Forty participants will get the standard twelve week drug course plus bot access. Logs will show how the bot is actually used, and surveys at four points will track smoking, adherence, and how acceptable and usable the tool feels. Set stop, amend, or go rules will judge whether a full trial is warranted, with an equity lens on who takes the tool up.
Catalog record
| CREATOR | Nadia Minian, Kamna Mehra, Mackenzie Earle, Sowsan Hafuth, Ryan Ting-A-Kee, Jonathan Rose, Scott Veldhuizen, Laurie Zawertailo, Matt Ratto, Osnat C Melamed, Peter Selby |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |